Secondary analysis and integration of existing data to study cancer risk and outcomes (R21; no clinical trials)
This R21 opportunity funds innovative secondary analyses and integration of existing clinical, genomic, environmental, surveillance, and behavioral datasets to elucidate cancer risk, progression, survival, and treatment response. Projects must use existing data (no new primary data collection; up to 10% of budget allowed for limited validation), include plans for harmonization and broad data s…
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim t…
Funding Source
Awards & funding
Eligibility
- Foreign eligibility: Non-domestic (non-U.S.) entities (foreign organizations) may apply. Non-domestic (foreign) components of U.S. organizations are eligible to participate, and foreign components (as defined in the NIH Grants Policy Statement) are allowed in applications.
- Require…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers